Prostaglandins in Severe Congestive Heart Failure: Relation to Activation of the Renin–Angiotensin System and Hyponatremia

New England Journal of Medicine

Volumn 310, Issue 6, 1984, Pages 347-352

  Dzau, Victor J ^a,b   Packer, Milton ^a,b   Lilly, Leonard S ^a,b   Swartz, Stephen L ^a,b   Hollenberg, Norman K ^a,b   Williams, Gordon H ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA H 3; INDOMETACIN; PROSTAGLANDIN; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ARTICLE; BLOOD AND HEMOPOIETIC SYSTEM; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; DRUG EFFICACY; DRUG THERAPY; ENDOCRINE SYSTEM; HEART; HUMAN; HYPONATREMIA; KIDNEY; ORAL DRUG ADMINISTRATION; RADIOIMMUNOASSAY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; THERAPY;

EID: 0021361317     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198402093100603     Document Type: Article

References (47)

1. Dzau VJ, Colucci WS, Hollenberg NK, Williams GH. Relation of the renin–angiotensin–aldosterone system to clinical state in congestive heart failure. Circulation 1981; 63: 645–51.
2. Thomas JA, Marks BH. Plasma norepinephrine in congestive heart failure. Am J Cardiol 1978; 41: 233–43.
3. Szatalowicz VL, Arnold PE, Chaimovitz C, Bichet D, Berl T, Schrier RW. Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. N Engl J Med 1981; 305: 263–6.
4. Riegger GAJ, Liebau G, Kochsiek K. Antidiuretic hormone in congestive heart failure. Am J Med 1982; 72: 49–52.
5. Needleman P, Bronson SD, Wyche A, Sivakoff M, Nieolaou KC. Cardiac and renal prostaglandin I2: biosynthesis and biological effects in isolated perfused rabbit tissues. J Clin Invest 1978; 61: 839–49.
6. Oliver JA, Sciacca R, Pinto J, Cannon PJ. Participation of the prostaglandins in the control of renal blood flow during acute reduction of cardiac output in the dog. J Clin Invest 1981; 67: 229–37.
7. Friedman PL, Brown EJ Jr, Gunther S, et al. Coronary vasoconstrictor effect of indomethacin in patients with coronary-artery disease. N Engl J Med 1981; 305: 1171–5.
8. McGiff JC, Crowshaw K, Terragno NA, et al. Release of a prostaglandinlike substance in renal venous blood in response to angiotensin II. Circ Res 1970; 27: Suppl 1:I-121–30.
9. Shebuski RJ, Aiken JW. Angiotensin II stimulation of renal prostaglandin synthesis elevates circulating prostacyclin in the dog. J Cardiovasc Pharmacol 1980; 2: 667–77.
10. Zusman RM, Keiser MR. Prostaglandin biosynthesis by rabbit renomedullary interstitial cells in tissue culture: stimulation by angiotensin II, bradykinin and arginine vasopressin. J Clin Invest 1977; 60: 215–23.
11. McGiff JC, Crowshaw K, Terragno NA. Malik KU, Lonigro AJ. Differential effect of noradrenaline and renal nerve stimulation on vascular resistance in the dog kidney and the release of a prostaglandin E-like substance. Clin Sci 1972; 42: 223–33.
12. Horton R, Zipser R, Fichman M. Prostaglandins, renal function and vascular regulation. Med Clin North Am 1981; 65: 891–914.
13. Mauer EF. The toxic effects of phenylbutazone (butazolidin): review of the literature and report of the twenty-third death following its use. N Engl J Med 1955; 253: 404–10.
14. Dick WC, De Ceulaer K. Nonsteroidal antirheumatic drugs. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of rheumatology. Philadelphia: WB Saunders, 1981:771–82.
15. Emanuel RL, Cain JP, Williams GH. Double antibody radioimmunoassay of renin activity and angiotensin II in human peripheral plasma. J Lab Clin Med 1973; 81: 632–40.
16. Underwood RH, Williams GH. The simultaneous measurement of aldosterone. Cortisol, and corticosterone in human peripheral plasma by displacement analysis. J Lab Clin Med 1972; 79: 848–62.
17. Lackritz R, Tulchinsky D, Ryan KJ, Levine L. Plasma prostaglandin metabolites in human labor. Am J Obstet Gynecol 1978; 131: 484–9.
18. Swartz SL, Williams GH, Hollenberg NK, Levine L, Dluhy RG, Moore TJ. Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man. J Clin Invest 1980; 65: 1257–64.
19. Rao GHR, Burris SM, Gerrard JM. White JG. Inhibition of prostaglandin synthesis in sheep vesicular microsomes by nitroblue tetrazolium and vitamin E. Prostaglandins Med 1979; 2: 111–21.
20. Packer M, Meller J, Medina N, Gorlin R, Herman MV. Importance of left ventricular chamber size in determining the response to hydralazine in severe chronic heart failure. N Engl J Med 1980; 303: 250–5.
21. Blumberg AL, Denny SE, Marshall GR, Needleman P. Blood vessel-hormone interactions: angiotensin, bradykinin, and prostaglandins. Am J Physiol 1977; 232: H305–10.
22. Nasjletti A, Malik KU. Interrelationships among prostaglandins and vasoactive substances. Med Clin North Am 1981; 65: 881–9.
23. Messina EJ, Weiner R, Kaley G. Inhibition of bradykinin vasodilation and potentiation of norepinephrine and angiotensin vasoconstriction by inhibi tors of prostaglandin synthesis in skeletal muscle of the rat. Circ Res 1975; 37: 430–7.
24. Malik KU, Ryan P, McGiff JC. Modification by prostaglandins E1 and E2, indomethacin and arachidonic acid of the vasoconstrictor responses of the isolated perfused rabbit and rat mesenteric arteries to adrenergic stimuli. Circ Res 1976; 39: 163–8.
25. Zusman RM. Prostaglandins. vasopressin, and renal water reabsorption. Med Clin North Am 1981; 65: 915–25.
26. Whorton AR, Misono K, Hollifield J, Frolich JC, Inagami T, Oates JA. Prostaglandins and renin release. I. Stimulation of renin release from rabbit renal cortical slices by PGI2. Prostaglandins 1977; 14: 1095–9.
27. Levine TB, Franciosa JA, Vrobel T, Cohn JN. Hyponatraemia as a marker for high renin heart failure. Br Heart J 1982; 47: 161–6.
28. Packer M, Medina N, Yushak M. Relationship between serum sodium concentration and the hemodynamic and clinical responses to convertingenzyme inhibition in severe heart failure. J Am Coll Cardiol (in press).
29. Brown JJ, Davies DL, Johnson VW, Lever AF, Robertson JIS. Renin relationships in congestive cardiac failure, treated and untreated. Am Heart J 1970; 80: 329–42.
30. Colucci WS, Dzau V, Marsh JD, et al. Neurohumoral responsiveness in CHF: relation to stress hormones and clinical condition. Circulation 1982; 66: Suppl 2: II-248. abstract.
31. Lilly LS, Dzau VJ, Williams GH, Hollenberg NK. Altered regional blood flow and hormonal responses to orthostasis in congestive heart failure. Circulation 1982; 66: Suppl 2: 11–249. abstract.
32. Ramsay DJ, Rolls BJ, Wood RJ. The relationship between elevated water intake and oedema associated with congestive cardiac failure in the dog. J Physiol (Lond) 1975; 244: 303–12.
33. Johnson AK, Mann JFE, Rascher W, Johnson JK, Ganten D. Plasma angiotensin II concentrations and experimentally induced thirst. Am J Physiol 1981; 240: R229–34.
34. Gould L, Zahir M, Ettinger S. Phentolamine and cardiovascular performance. Br Heart J 1969; 31: 154–62.
35. Curtiss C, Cohn JN, Vrobel T, Franciosa JA. Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure. Circulation 1978; 58: 763–70.
36. Dzau VJ, Colucci WS, Williams GH, Curfman G, Meggs L, Hollenberg NK. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. N Engl J Med 1980; 302: 1373–8.
37. Levin RI, Jaffe EA, Weksler BB, Tack-Goldman K. Nitroglycerin stimulates production of prostacycline by cultured human cndothelial cells. J Clin Invest 1981; 67: 762–9.
38. Morcillo E, Pitt B, Reid P. Attenuation of the cardiovascular effects of nitroglycerin by indomethacin. Am J Cardiol 1978; 41: 367. abstract.
39. Packer M, Meller J, Medina N, Yushak M, Gorlin R. Attenuation of the effects of nitroprusside in severe heart failure by indomethacin. Circulation 1981; 64: Suppl 4: IV-308. abstract.
40. Rubin LJ, Lazar JD. Influence of prostaglandin synthesis inhibitors on pulmonary vasodilatory effects of hydralazine in dogs with hypoxic pulmonary vasoconstriction. J Clin Invest 1981; 67: 193–200.
41. Swartz SL, Williams GH. Angiotensin-converting enzyme inhibition and prostaglandins. Am J Cardiol 1982; 49: 1405–9.
42. Moore TJ, Crantz FR, Hollenberg NK, et al. Contribution of prostaglandins to the antihypertensive action of caplopril in essential hypertension. Hypertension 1981; 3: 168–73.
43. Goldstone R, Martin K, Zipser R, Horton R. Evidence for a dual action of converting enzyme inhibitor on blood pressure in normal man. Prostaglandins 1981; 22: 587–98.
44. Zusman RM. Captopril stimulates prostaglandin E2 synthesis in vitro: possible mechanism of antihypertensive action. Clin Res 1981; 29: 362A. abstract.
45. Bolen J, Holloway E, Zencr JC, Harrison DC, Alderman EL. Evaluation of left ventricular function in patients with aortic regurgitation using afterload stress. Circulation 1976; 53: 132–8.
46. Oliw E, Kövér G, Larsson C, Änggård E. Reduction by indomethacin of furosemide effects in the rabbit. Eur J Pharmacol 1976; 38: 95–100.
47. Frölich JC, Hollifield JW, Dormois JC, et al. Suppression of plasma renin activity by indomethacin in man. Circ Res 1976; 39: 447–52.